Neurol. pro Praxi, 2006; 6: 315-318

Léčba intracerebrálního krvácení – skepse nebo optimizmus?

doc. MUDr. Jiří Bauer, CSc.
Neurologická klinika 1. LF UK a VFN, Praha

Významný rozvoj medicínské techniky, především v oblasti zobrazovacích metod, umožňuje v současné době zkvalitnění terapie cévních mozkových příhod. Intracerebrální krvácení je emergentní stav, který bezpodmínečně vyžaduje co nejrychlejší hospitalizaci nemocného na jednotce neurointenzívní péče, provedení urgentní diagnostiky a okamžité zahájení adekvátní terapie podle individuálního plánu. Pokrok v terapii spočívá především v poskytnutí komplexní intenzívní péče, v rasantnějším snižování vysokého krevního tlaku v akutní fázi onemocnění a hlavně v přímém zásahu do hemokoagulačních mechanismů, kde velmi slibnou možností zamezení progrese hematomu představuje léčba rekombinantním aktivovaným VII plazmatickým faktorem (rFVIIa). Léčba antiedémová i chirurgické intervence zatím nesplňují očekávání na ně kladená.

Keywords: intracerebrální hematom, komplexní intenzívní péče, rekombinantní aktivovaný VII plasmatický faktor

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bauer J. Léčba intracerebrálního krvácení – skepse nebo optimizmus? Neurol. praxi. 2006;7(6):315-318.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bernstein RA, Del-Signore M. Recent advances in the management of acute intracerebral hemorrhage. Current Neurology and Neuroscience Reports 2005; 5 (6): 483-487. Go to original source... Go to PubMed...
    2. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987-993. Go to original source... Go to PubMed...
    3. Brott TG, Broderick JP, Kothari R et al. Early Hemorrhage Growth in Patients With Intracerebral Hemorrhage. Stroke 1997; 28: 1-5. Go to original source... Go to PubMed...
    4. Brown DL, Morgenstern LB. Stopping the Bleeding in Intracerebral Hemorrhage. N Engl J Med 2005; 352: 828-830. Go to original source... Go to PubMed...
    5. Cordonnier CH. From Trials to, ,Real Life". Stroke; 2005: 36: 2527. Go to original source... Go to PubMed...
    6. Diringer MN, Aiyagari V, Shackleford AM, Brody DL. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Blood 2003; 11: 109.
    7. Flaherty ML, Woo D, Haverbusch M et al. Potential applicability of recombinant factor VIIa for intracerebral hemorrhage. Stroke: 2005; 36: 2660-2664. Go to original source... Go to PubMed...
    8. Freeman WD, Brott TG, Barrett MK at al. Recombionant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clinic Proceeding 2004; 79 (12): 1495-1500. Go to original source... Go to PubMed...
    9. Juvela S, Kase CS. Advances in Intracerebral Hemorrhage Management. Stroke 2006; 37: 301-304. Go to original source... Go to PubMed...
    10. Lin J, Hanigan WC, Tarantino M, Wang J. The use of recombinant activated factor VII to reverse Warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 2003; 98: 737-740. Go to original source... Go to PubMed...
    11. Mathew LF, Woo D, Haverbusch M et al. Potential Applicability of Recombinant Factor VIIa for Intracerebral Hemorrhage. Stroke 2005; 36: 2660. Go to original source... Go to PubMed...
    12. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 2003; 1 (34): 224-229. Go to original source... Go to PubMed...
    13. Mayer SA, Brun, NC, Begtrup K et al. Recombinant activated Factor VII for acute intracerebral haemorrhage. N Engl J Med 2005; 352: 777-785. Go to original source... Go to PubMed...
    14. Mendelow AD, Gregson BA, Fernandes HM et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral hematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomized trial. Lancet 2005; 365: 387-397. Go to original source...
    15. Park P, Fewel ME, Thompson BG, Hoff JT. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery 2003; 58: 34-39. Go to original source... Go to PubMed...
    16. Powers WJ, Zazulia AR, Videon TO et al. Autoregulation of cerebral blood flow surrounding acute (6-22 hours) intracerebral hemorrhage. Neurology 2001; 57: 18-24. Go to original source... Go to PubMed...
    17. Qureshi AI, Tuhrim S, Broderick JP et al. Spontaneous intracerebral haemorrhage. N Engl J Med 2001; 344: 1450-1460. Go to original source... Go to PubMed...
    18. Rincon F, Mayer SA. Novel therapies for intracerebral hemorrhage. Current Opinion in Critical Care 2004; 2 (10): 94-100. Go to original source... Go to PubMed...
    19. Roitberg B, Emechebe KO, Amin HS, Mucksavage J, Tesoro E. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: A retrospective comparative study. Neurosurgery 2005; 5 (57): 832-835. Go to original source... Go to PubMed...
    20. Sorensen B, Johansen P, Nielsen GL et al. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous systém bleeding during warfarin thromboprophylaxis: Clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003; 5: 469-477. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.